Quoin Pharmaceuticals, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, net loss was USD 4.71 million compared to USD 4.35 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6375 USD | +1.19% | -10.20% | -87.00% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
1st Jan change | Capi. | |
---|---|---|
-87.00% | 2.35M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |